Research and Development

The Research and Development team at Inversago Pharma is dedicated to advancing innovative cannabinoid-1 receptor therapies through rigorous preclinical studies and clinical trials. Comprising experts in pharmacology, clinical operations, and regulatory affairs, the team collaborates to ensure the development of safe and effective treatments for metabolic disorders, such as Prader-Willi Syndrome, diabetes, and NASH, while adhering to quality and compliance standards.